On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Sepsis is currently defined as life-threatening organ dysfunction caused by a dysregulated host response to infection and is estimated globally to be responsible for 11 million deaths each year. Despite the therapeutic potential of immunomodulatory therapy, there have been very few successful trials of such agents in patients with this clinical syndrome. I will describe recent efforts to better understand the pathophysiology of sepsis and stratify the maladaptive host response into sub phenotypes associated with specific mechanisms, showing how this can reveal potential targets and biomarkers to guide their therapeutic use.
